454 Life Sciences and Max Planck Institute Complete Draft 1X Sequence of Neanderthal Genome
Completion of more than 3 billion bases of sequenced Neanderthal DNA brings closure to the sequencing stage of a project initiated two and a half years ago
The Neanderthal project, spearheaded by Dr. Svante Pääbo, Director of the Institute’s Department of Evolutionary Anthropology and Michael Egholm, Chief Technology Officer at 454 Life Sciences, developed from the results of a study published in Nature in 2006, detailing the ability of 454 Sequencing to determine large amounts of nuclear DNA sequences from late Pleistocene animals such as cave bears, mammoths, as well as the Neanderthal. The goal of the project is to identify areas in the genome where humans have undergone rapid evolution since the split from Neanderthals: the genetic changes that define us as human. This analysis is achieved by comparing the Neanderthal reference to the human and chimpanzee reference genome sequences as well as to the genomic variation among humans today.
Together the groups have overcome a number of technical obstacles in order to arrive at this first view of the extinct form of human, including difficulties with highly-degraded and contaminated DNA and the limited availability of precious fossil material. A number of key milestones have been achieved over the course of the project, including the complete mitochondrial genome sequence, published in Cell in 2008. Using the chimpanzee and human mitochondrial DNA sequences as reference points, the number of nucleotide differences found in the Neanderthal mitochondrial DNA establishes the divergence date between human and Neanderthal mtDNAs at 660,000 +/- 140,000 years.
The final draft sequence includes more than three billion bases of Neanderthal DNA and covers approximately two-thirds of the genome. During the last phase of the project, micro-reads generated by the Solexa technology were used to achieve the one-fold coverage. In order to aid in the analysis of the Neanderthal genome, Dr. Pääbo has organized a consortium of researchers from around the world that plans to publish their results later this year.
Most read news
Organizations
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.